LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
24h
Current
Min
7.86
Max
8.07
Recommendations | Buy |
---|---|
12 Months Forecast | +111.97% upside |
Next Earnings | 8 Aug 2025 |
---|
By Acuity
50%
50%
154 / 380 Healthcare
By Trading Central
Confidence
Weak Bearish Evidence
7.245 / 7.64 Support & Resistance
Past performance is not a reliable indicator of future results.
7 Mar 2025, 21:54 UTC
Atara Biotherapeutics to Cut Half of Workforce Amid Restructuring
DJ
Read
16 Jan 2025, 16:17 UTC
Atara Shares Sink After FDA Stalls Cancer Treatment
DJ
Read
16 Jan 2025, 14:31 UTC
FDA Rejects Atara's Request to Bring Blood Cancer Treatment to Market
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 17 USD 111.97%
High 17 USD
Low 17 USD
Based on 1 Wall Street analysts offering 12 month price targets forAtara Biotherapeutics Inc - Dist in the last 3 months.
By TipRanks
Buy
1 ratings
1
Buy
0
Hold
0
Sell
Based on 1 analysts giving stock ratings to Atara Biotherapeutics Inc - Dist in the past 3 months.
By Trading Central
Short Term
Weak Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Above average
$